What is a multiple sclerosis (MS) lesion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A multiple sclerosis (MS) lesion is an area of focal hyperintensity on a T2-weighted or proton density-weighted sequence, typically round to ovoid in shape, and at least 3 mm in diameter.

Key Characteristics of MS Lesions

  • They are usually visible on at least two consecutive slices to exclude artefacts or small hyperintensities
  • MS lesions tend to affect specific white matter regions, such as the periventricular and juxtacortical white matter, the corpus callosum, infratentorial areas, and the spinal cord
  • They can be gadolinium-enhancing, which plays an important role in evaluating patients suspected of MS, and can support dissemination in time when it occurs in some lesions but not others

Location and Distribution of MS Lesions

  • MS lesions typically develop in both hemispheres, but their distribution is often mildly asymmetric in the early stages
  • They can occur in any CNS region, but are more common in specific areas such as the periventricular and juxtacortical white matter
  • In the spinal cord, MS lesions are often small, covering less than two vertebral segments, and usually less than half of the cord area, and are typically located in the periphery of the spinal cord, mainly in the lateral or dorsal columns

Red Flags for MS Lesions

  • Longitudinally extensive lesions extending over three or more vertebral segments
  • Prominent involvement of the central grey matter
  • Swelling of the spinal cord
  • Leptomeningeal or nerve root involvement
  • Cavitation or evidence of micro/macrobleeds As noted by 1, the definition of an MS lesion is based on its appearance on MRI, and the location and distribution of lesions can help support a diagnosis of MS. Additionally, 1 highlights the importance of considering the specific characteristics of each individual lesion, as well as the overall patterns of lesions, to support the diagnosis of MS or other conditions. Furthermore, 1 discusses the role of gadolinium enhancement in evaluating MS lesions, and 1 and 1 provide guidance on the interpretation of spinal cord lesions in MS.

From the Research

Definition of Multiple Sclerosis Lesions

A multiple sclerosis (MS) lesion is characterized by:

  • Focal demyelination
  • Inflammation
  • Scar formation
  • Variable axonal destruction 2 MS lesions can occur in both white and grey matter, with different pathological characteristics:
  • White matter lesions (WMLs) are pathologically characterized by the presence of immune cells that infiltrate the CNS 3
  • Grey matter lesions (GMLs) are less inflammatory, with less macrophage and lymphocyte infiltration, and are associated with significant axonal transection and neuronal loss 4

Pathological Characteristics

The pathological hallmarks of MS lesions include:

  • Demyelination
  • Inflammation
  • Axonal damage
  • Glial cell activation 5 The nature of the soluble factors responsible for demyelinating activity in MS is currently undefined, but it is thought that inflammation drives tissue injury at all stages of the disease 5

Types of MS Lesions

There are different types of MS lesions, including:

  • White matter lesions (WMLs)
  • Grey matter lesions (GMLs)
  • Cortical lesions, which can extend inward from the surface of the brain and are often underestimated by standard histochemical myelin staining methods 4
  • Subpial demyelination, which can occur in all cortical areas of the brain and is associated with the progressive phases of disease 4

Clinical Significance

The clinical significance of MS lesions is not yet fully understood, but it is thought that they contribute to the development of symptoms and disability in MS patients:

  • The formation of MS lesions is thought to be an important factor in the progression of the disease 2
  • The presence of grey matter lesions has been associated with the progressive phases of disease, and may be an important factor in the development of disability in MS patients 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pathological differences between white and grey matter multiple sclerosis lesions.

Annals of the New York Academy of Sciences, 2015

Research

Grey matter pathology in multiple sclerosis.

Acta neurologica Scandinavica. Supplementum, 2006

Research

Multiple Sclerosis Pathology.

Cold Spring Harbor perspectives in medicine, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.